<DOC>
	<DOCNO>NCT02802007</DOCNO>
	<brief_summary>This prospective , non-randomized , open trial conduct overweight obese individual . The primary objective evaluate safety Elipse™ Intragastric Balloon System treatment overweight obese individual . The secondary objective collect efficacy device performance information assist future trial design device iteration .</brief_summary>
	<brief_title>Pilot Trial Elipse™ Intragastric Balloon System Treatment Overweight Obese Individuals</brief_title>
	<detailed_description />
	<mesh_term>Overweight</mesh_term>
	<criteria>Patient , female male , 18 64 year age . Patient must able understand willing sign IC document . Patient must willing participate aspect trial duration trial . Patient must motivate lose weight realistic expectation . Patient must complete screen requirement complete one week Daily Eating Diaries Daily Weight Logs . Patient must pass Screening Behavioral Interview . Patient must understand even though undergo Elipse™ Treatment , must follow physician guideline eat behavior lifestyle modification weight loss . Patient BMI ≥ 27.0 . Females must willing use contraception throughout course trial exit . Patients must primary care physician follow comorbid condition . Patients must live within 160 kilometer trial site plan move vicinity trial duration . Patients must fully ambulatory without chronic orthopedic disease reliance crutch , walker wheelchair could preclude exercise trial . Patient must stable home environment supportive patient 's effort lose weight . If Patient exsmoker , must exsmoker year . Patient agree refrain reconstructive and/or cosmetic surgery may affect body weight study mammoplasty lipoplasty . Patient symptomatic congestive heart failure , cardiac arrhythmia unstable coronary artery disease . Patient preexist respiratory disease chronic obstructive pulmonary disease ( COPD ) , pneumonia cancer . Female subject pregnant ( i.e. , positive urine blood pregnancy test prior surgery ) , suspect pregnant , lactate childbearing potential refuse use adequate contraception study . Patient previous bariatric gastric surgery . Patient history acute pancreatitis . Patient history small bowel obstruction . Patients history abdominal and/or pelvic surgery EXCLUDING ONE follow surgery perform least 12 month prior Elipse™ Treatment : cesarean section , diagnostic laparoscopy , laparoscopic appendectomy , laparoscopic cholecystectomy . ( For example : patient 2 cesarean section , one cesarean section laparoscopic appendectomy would exclude . If patient one cesarean section may include . ) Patient history of/or sign and/or symptom esophageal , gastric , duodenal disease include limited hiatal hernia &gt; 2 centimeter ( cm ) , inflammatory disease , cancer , varix . Patient specific diagnose genetic hormonal cause obesity hypothyroidism PraderWilli syndrome . Patient poorly control diabetes . Patient renal and/or hepatic insufficiency . Patient systemic infection abscess site treat . Patient undergo chronic steroid therapy . Patient undergo immunosuppressive therapy . Patient presently take heparin , coumadin , warfarin , anticoagulant medication impede coagulation platelet aggregation . Patient unable unwilling discontinue use aspirin and/or nonsteroidal antiinflammatory agent ( NSAIDs ) least 14 day prior treatment continue 14 day posttreatment . Patient history pulmonary embolism blood coagulation disorder . Patient unable discontinue either prescription counter weight loss medication least 30 day prior treatment continue remainder trial Patient cardiac pacemaker electric implantable device . Patient history use tobacco product include limited cigar , cigarette , pipe within 12 month prior enrollment . Patient poorly control psychiatric disease depression . Patient eat disorder include night eat syndrome ( NES ) , Bulimia , binge eat disorder , continuously graze food majority day . Patient uncontrolled life stressor baseline divorce , illness/death personal acquaintance . Patient currently use history illicit drug use excessive alcohol use . Patient participate clinical study investigational new drug , biological , therapeutic device within ≤ 28 day prior enrollment trial , agree abstain participation clinical trial kind trial . Patient sufficient medical health determine PI participate trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>